Preventing blood clots in people with cancer
Part of Cancer, Heart & circulation, Lungs & breathing clinical trials.
This trial tests a new anticoagulant medication to treat and prevent blood clots in patients with active cancer. You may qualify if you have a recent clot in your leg or lungs and are already taking a blood thinner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid tumor or certain blood cancers (like lymphoma or multiple myeloma)
- You have a recent (within 5 days) blood clot in your leg or lung found by imaging
- Your doctor plans to treat you with a blood thinner pill for at least 3 to 6 months
- You are able to perform daily activities with some help (ECOG 0-2)
- You do not have a high risk of bleeding or a bleeding disorder
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new medicine called vortosiran can help prevent future blood clots. It's for people who've already had a blood clot or who have cancer and are starting chemotherapy.
This study tests two experimental drugs, REGN7508 and REGN9933, to see if they can safely prevent blood clots in the arm or chest in people who need a PICC line. If you are getting a PICC for treatments like chemotherapy or antibiotics, you may be able to join.
This trial tests a new drug called REGN7508 to see if it can prevent dangerous blood clots in people with advanced or metastatic solid tumors. People with a higher risk of clots (based on a simple score or tumor genetics) may qualify.
This trial tests whether continuing a lower dose of blood thinners can prevent another blood clot in cancer patients who have had a clot in an arm or chest catheter. It may help find a safer way to prevent future clots.
This study compares two blood-thinning medications, edoxaban and apixaban, in people who have both cancer and a blood clot. The goal is to see which one works better and is safer for preventing another clot while treating your cancer.
This study tests if the blood thinner apixaban is safe and effective for cancer patients who have low platelets and a recent blood clot. It may offer a treatment option for those who cannot take standard blood thinners.
Hear when a new Venous Thromboembolism (VTE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.